Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.50 2.51% 143.00 140.00 146.00 150.00 139.50 139.50 518,383 13:33:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.7 -9.1 -8.0 - 168

Shield Therapeutics Share Discussion Threads

Showing 5751 to 5772 of 6800 messages
Chat Pages: Latest  236  235  234  233  232  231  230  229  228  227  226  225  Older
DateSubjectAuthorDiscuss
01/5/2020
17:59
Good work peachie.
montyhedge
01/5/2020
17:03
From LSE .... 12.5 metric tonnes of ferric maltol ( in RNS) equates to .... 7.4m bottles of 56 caps at 30mg each. A lot. If you guess a 20% royalty on gross revenue and a UK list price of £47.60 in all markets that is £70m from that one order of API. If anyone gets a different number I'd like to see if that is right or not. Not insignificant! And that’s just for starters.
peachie 74
01/5/2020
15:22
Good points Cranky
peachie 74
01/5/2020
15:18
There’s no way the H2H review comes out any differently than what we already know and something a little worse. It’s not going to resolve it. Anyway the H2H is still a good basis for pricing as even accounting for some patients not complying with oral, those patients just go on to get an IV. So from an outcomes perspective it will be the same for both arms but the cost of the oral arm is hugely lower. Added to that the benefit patients that don’t want to take IV because it means getting sick enough to need it. Like I said, Norgine are freakin’ hopeless if they don’t get this product priced.
crankyman
01/5/2020
14:52
Cheers Nobby. A lot of H2H still applicable though. And wasn’t it just on GI related Iron deficiency ? Anyway. The deal will be good. We know that much. Can sell a lot online. Can only get a price for a 1000 at 120 .....
peachie 74
01/5/2020
14:38
Well you have to think the HtoH fiasco will affect the upfront and the milestones etc. I know it's not on the label in the US currently but the plan would have been to submit the data at the earliest opportunity. Around here $50 million upfront was being suggested so I will go for $30-40 million upfront.
nobbygnome
01/5/2020
14:21
What they did first thing should be on Crimewatch ! Any ideas people , how many millions will be involved in US deal. BTW I wonder if Norgine will give the money back if the H2H shown to be valid. RNS did say a lot of it all still applicable
peachie 74
01/5/2020
13:34
Market makers are professional pick pockets.
montyhedge
01/5/2020
12:51
Very wide spread putting off trading. Come on, make a proper market FFS!
nobbygnome
01/5/2020
12:49
And that market cap will look nothing when the US deal comes through.
peachie 74
01/5/2020
12:33
Company loses 2m so should be down around 2% on the day due to mcap around 100m
78steve
01/5/2020
11:52
Great opportunity for top ups now. Got some more around 112 will add more further down it goes. Dyor
78steve
01/5/2020
09:30
Market makers shaking the tree, see which weak holders fall out.
montyhedge
01/5/2020
09:23
Well, I think the MMs thought they could scare a few sales. Thats not happened and no real reason why it should. The company is still very much undervalued IMO
peachie 74
01/5/2020
08:52
That is the point that was a fake markdown as they wouldnt let you buy any at markdown prices
78steve
01/5/2020
08:32
We were at this level BEFORE FDA approval And we are now in a better cash position and US deal due anytime soon. Anyone got any ideas of the millions that maybe involved in the US deal ? Bearing in mind the millions upfront by ASK in China who are "behind" in terms of getting to market
peachie 74
01/5/2020
08:31
That mark down was silly. Didn't have the spares otherwise i would have tried to buy more. NO brainer here
frrinvest
01/5/2020
08:23
getting quoted for max 1000 at 120 Good to see that during that people can obviously see in the middle of a pandemic, the RNS borders on being very positive in relative terms. but these are not normal times I had actually worried that supplies would be hit slowing production, with the US deal around the corner..but all good
peachie 74
01/5/2020
08:22
The product still is what it is..a derisked FDA broad label approved IV alternative for a multi billion dollar industry. Fact. Nothing in the RNS goes against this. The MMs deserve to get stuffed. People holding these obviously know the worth. MMs trying to get them on the cheap
peachie 74
01/5/2020
08:16
Managed to buy 2000 at 105 via spreadbet before they stopped me. Good to see the MMs getting stuffed...
nobbygnome
01/5/2020
08:13
Well they wouldnt let me buy any been trying for 15 minutes. HL takes way too long since Covid19. Just says pending order for too long and nothing gets bought
78steve
01/5/2020
08:11
Thinking about it , the only negative is money back to Norgine.....Which will be peanuts compared to any US deal....never mind the rest of the world I topped up yesterday....
peachie 74
Chat Pages: Latest  236  235  234  233  232  231  230  229  228  227  226  225  Older
ADVFN Advertorial
Your Recent History
LSE
STX
Shield The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200920 12:28:24